IDEAYA Biosciences, Inc. - Common Stock — キャッシュフロー (NASDAQ:IDYA) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー 55.46 M-55.78 M-87.17 M-115.22 M-247.58 M-71.1 M -85.93 M 投資活動によるキャッシュフロー -146.24 M-69.67 M-33.4 M-158.46 M-502.56 M69.98 M 109.11 M 財務活動によるキャッシュフロー 128.75 M145.45 M97.17 M362.72 M677.55 M29.78 M 4.82 M フリーキャッシュフロー 55.46 M-55.78 M-87.17 M-115.22 M-247.58 M-73.47 M -87.93 M

ニュース

IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Misses Revenue Estimates

Stocks Settle Higher in Hopes for an Agreement to End the Iran War

IDEAYA Biosciences, Inc. (IDYA) Discusses Topline Results from OptimUM-02 Trial Evaluating Darovasertib and Crizotinib in HLA-A2-Negative Metastatic Uveal Melanoma - Slideshow (NASDAQ:IDYA) 2026-04-13

Ideaya Biosciences: Stock Buoyant On Good mUM Data - But Approval Not A Formality (IDYA)

IDEAYA Biosciences, Inc. (IDYA) Discusses Topline Results from OptimUM-02 Trial Evaluating Darovasertib and Crizotinib in HLA-A2-Negative Metastatic Uveal Melanoma Transcript

Stocks Recover as Oracle Leads Software Companies Higher

Ideaya Biosciences Surges On Promising Results For Hard-To-Treat Melanoma

Stocks Retreat as US Set to Blockade the Strait of Hormuz

IDEAYA Eye Cancer Trial Data Beats Standard Therapy, Stock Soars - IDEAYA Biosciences (NASDAQ:IDYA)

Ideaya Biosciences Stock: Key Pivotal Data Imminent (NASDAQ:IDYA)

Truist、MTAP開発プログラムでIdeaya Biosciences株の投資判断を維持

Truist reiterates Ideaya Biosciences stock rating on MTAP program